Drug intelligence / Profile preview

N-ETSD

Development stage
Discontinued
Modality
DNA Vaccines → Plasmid DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
Administration
Subcutaneous, Sublingual, Oral, Intranasal
01

Overview

N-ETSD is a modified SARS-CoV-2 nucleocapsid (N) protein antigen, specifically an Enhanced T-cell Stimulation Domain. It is designed to enhance T-cell stimulation by directing the N antigen to the endosomal/lysosomal compartment, thereby increasing its potential for presentation via MHC class I and II pathways. N-ETSD is a key component of a dual-antigen COVID-19 vaccine, hAd5-S-Fusion+N-ETSD, which utilizes a human adenovirus serotype 5 platform to deliver both the modified N protein and a modified spike (S-Fusion) protein to elicit robust cellular immune responses.

Other names
Enhanced T-cell Stimulation Domain (N-ETSD)N antigen modified with an Enhanced T-cell Stimulation Domain
02

Targets

MHC I (MHC class I})MHC II (Major histocompatibility complex class II receptor)

Beyond the preview

Go deeper on N-ETSD.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-ETSD.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call